Newborn affected by other maternal medication
ICD-10 P04.18 is a billable code used to indicate a diagnosis of newborn affected by other maternal medication.
P04.18 refers to newborns who are affected by maternal medications, specifically those substances that may be transmitted through the placenta or breast milk. This includes exposure to noxious substances such as illicit drugs, alcohol, and tobacco during pregnancy or lactation. Maternal drug use can lead to a range of neonatal complications, including withdrawal symptoms, growth restrictions, and developmental delays. Alcohol exposure can result in fetal alcohol spectrum disorders, while tobacco use is associated with low birth weight and respiratory issues. The clinical presentation of affected newborns may vary widely, necessitating careful assessment and management in the neonatal intensive care unit (NICU) or nursery. Accurate coding requires thorough documentation of maternal history, substance use patterns, and any observed neonatal symptoms to ensure appropriate care and follow-up.
Detailed maternal history, including substance use, prenatal care, and any interventions during pregnancy.
Newborns presenting with withdrawal symptoms, respiratory distress, or growth restrictions due to maternal substance use.
Consideration of potential long-term developmental impacts and the need for multidisciplinary follow-up.
Documentation of ongoing assessments and developmental milestones in infants affected by maternal substance use.
Pediatric follow-up for infants with fetal alcohol spectrum disorders or other complications from maternal drug use.
Awareness of the need for early intervention services and family support.
Used when a newborn affected by maternal medication requires initial evaluation in the NICU.
Document the newborn's condition, maternal history, and any interventions performed.
Neonatologists should ensure comprehensive assessments are documented.
Documentation must include a detailed maternal history of substance use, any observed neonatal symptoms, and the management plan for the newborn.
